Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022

Rhea-AI Summary

Cannara Biotech Inc. (TSXV: LOVE, OTCQB: LOVFF, FRA: 8CB) will host a webcast investor presentation on August 17, 2022, at 2:00 PM ET. CFO Nicholas Sosiak will discuss key aspects of the company's operations, followed by a Q&A session for investors. Cannara is a leading producer of premium-grade cannabis products in Canada, with extensive facilities in Quebec capable of producing 125,000 kg annually. Interested participants must pre-register for the event via the provided link. An archived version will be available on the company’s website post-event.

MONTREAL, Aug. 10, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada, and the largest in Quebec, today announced that it will host a webcast investor presentation on Wednesday, August 17^th, 2022, at 2:00 PM ET. During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key areas of Cannara's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, please pre-register at the following link:

Webcast Link: https://event.webcasts.com/starthere.jsp?ei=1559060&tp_key=1c1f25226e 

An archived version of the webcast and presentation will be available on the Company's website, https://investors.cannara.ca/news-events/company-events-cannara-biotech-quebec-inc/

About Cannara Biotech Inc.

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Québec and Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 125,000kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cannara-biotech-inc-to-host-investor-webcast-on-august-17th-2022-301603322.html

SOURCE Cannara Biotech Inc.

FAQ

When is Cannara Biotech's investor webcast?

The investor webcast is scheduled for August 17, 2022, at 2:00 PM ET.

Who will present during the Cannara Biotech webcast?

CFO Nicholas Sosiak will conduct the presentation during the webcast.

How can I attend the Cannara Biotech investor webcast?

You can attend the webcast by pre-registering at the provided link in the press release.

What is Cannara Biotech known for?

Cannara Biotech is a vertically integrated producer of premium-grade cannabis and derivative products in Canada.

What production capacity does Cannara Biotech have?

Cannara Biotech has the capacity to produce 125,000 kg of cannabis annually from its facilities in Quebec.

Will the Cannara Biotech webcast be available after it airs?

Yes, an archived version of the webcast will be available on Cannara's website.